From Medscape Diabetes & Endocrinology

Medscape Medical News from the:

American Society for Bone and Mineral Research (ASBMR) 2013 Annual Meeting

October 04 - 07, 2013; Baltimore, Maryland

This coverage is not sanctioned by, nor a part of, the American Society for Bone and Mineral Research.

Conference News

ASBMR Osteoporosis Drug Denosumab Shows Benefit to 8 Years
Medscape Medical News, October 15, 2013
ASBMR Debate Continues on Osteoporosis Treatment in CKD
Medscape Medical News, October 14, 2013
ASBMR TZD Fracture Risk Quickly Reverses With Discontinuation
Medscape Medical News, October 11, 2013
ASBMR Clopidogrel Contribution to Fracture Risk in Stroke 'Minor'
Medscape Medical News, October 11, 2013
ASBMR Once-a-Year Zoledronic Acid Preserves Bone in Elderly, Frail
Medscape Medical News, October 9, 2013
ASBMR Combo Therapy Sustains Bone-Density Improvements
Medscape Medical News, October 9, 2013
ASBMR New Data Dispute Calcium Cardiovascular Risk in Both Sexes
Medscape Medical News, October 8, 2013
ASBMR Risedronate for Bone Loss With Breast-Cancer Treatment
Medscape Medical News, October 8, 2013
ASBMR SSRI Fracture Risk Exceeds That of Corticosteroids and PPIs
Medscape Medical News, October 7, 2013
ASBMR Sarcopenia Plus Low Bone Mass Increases Fracture Risk
Medscape Medical News, October 7, 2013

Medscape Diabetes & Endocrinology© WebMD, LLC

Previous Coverage

ASBMR 2012 Annual Meeting

ASBMR 2011 Annual Meeting

ASBMR 2010 Annual Meeting

All material on this website is protected by copyright, Copyright © 1994-2018 by WebMD LLC. This website also contains material copyrighted by 3rd parties.